Walgreen Cool N Heat Maximum Strength Pain Relieving

For topical application, Menthol, Unspecified Form is typically used as follows:

• Creams/Gels: Apply a thin layer to the affected area no more than 3 to 4 times daily.
• Patches: Apply one patch to the affected area once or twice daily as directed by the packaging or a physician.
• Lozenges: Dissolve one lozenge slowly in the mouth every 2 hours as needed for cough or throat irritation.

• Children 12 years and older: Same as adult dosing.
• Children under 12 years: Consult a pediatrician. Many high-concentration menthol products are not recommended for young children due to the risk of localized skin reactions or accidental ingestion.

Renal Impairment

No dosage adjustments are typically required for topical use due to low systemic absorption. However, patients with severe renal failure should use extensive topical applications with caution.

Hepatic Impairment

No specific adjustments are required for topical use. Systemic use (oral) should be monitored in patients with significant liver dysfunction.

Elderly Patients

Elderly patients may have thinner skin, which can increase the risk of irritation or systemic absorption. It is recommended to start with the lowest effective concentration.

1. 1Clean the Area: Wash and dry the affected skin before application.
2. 2Application: Rub the cream or gel gently until it is absorbed. If using a spray, ensure even coverage.
3. 3Hand Hygiene: Wash hands thoroughly with soap and water immediately after application to avoid transferring the medication to the eyes or mucous membranes.
4. 4Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) away from direct heat or open flames, as menthol is flammable.

If you miss a dose, apply it as soon as you remember. If it is almost time for the next application, skip the missed dose. Do not double the amount applied to 'catch up.'

Signs of topical overdose include severe skin redness, burning, or blistering. If ingested, menthol can be toxic, leading to symptoms such as abdominal pain, dizziness, vomiting, rapid heartbeat, and in severe cases, seizures or coma. In case of ingestion, contact a Poison Control Center or seek emergency medical help immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Most patients tolerate topical Menthol, Unspecified Form well. Common reactions include:

• Cooling Sensation: A strong feeling of cold at the site of application, which is a normal pharmacological effect.
• Mild Redness: Temporary flushing of the skin due to increased blood flow.
• Tingling: A slight 'pins and needles' feeling shortly after application.

• Skin Irritation: Increased sensitivity or a rash at the application site.
• Dryness: Some formulations, particularly gels containing alcohol, may dry the skin.
• Contact Dermatitis: An itchy, red rash that develops after repeated use.

• Chemical Burns: Severe skin damage, especially if used with tight bandages or heating pads.
• Hypersensitivity Reactions: Localized swelling or hives.
• Nausea: Reported in rare cases of systemic absorption from large-scale topical use.

> Warning: Stop taking Menthol, Unspecified Form and call your doctor immediately if you experience any of these.

• Anaphylaxis: Signs include difficulty breathing, swelling of the face or throat, and severe dizziness.
• Severe Blistering: Development of large blisters or skin peeling (sloughing) at the application site.
• Severe Burning: Pain that is intense and does not subside within minutes of application.
• Toxicity Symptoms: If accidentally ingested, watch for confusion, ataxia (loss of muscle coordination), or respiratory depression.

Prolonged use of Menthol, Unspecified Form on the same skin area may lead to chronic skin irritation or sensitization, making the user more likely to develop allergic reactions to mint-related products in the future.

No FDA black box warnings currently exist for Menthol, Unspecified Form. However, the FDA has issued safety communications regarding the risk of serious skin burns with certain OTC topical muscle and joint pain relievers containing menthol.

Report any unusual symptoms to your healthcare provider.

Menthol, Unspecified Form is for external use only. It should never be applied to open wounds, damaged skin, or sensitive areas like the eyes and genitals. If the product gets into the eyes, rinse thoroughly with cool water for several minutes.

No FDA black box warnings for Menthol, Unspecified Form.

• Allergic Reactions: Patients with a known allergy to peppermint oil or menthol should avoid these products. Anaphylaxis, though rare, has been documented.
• Chemical Burns: According to a 2024 FDA safety update, users should be aware that some menthol products can cause second- or third-degree burns. Discontinue use if you feel significant pain.
• Heat Application: Never use a heating pad, electric blanket, or hot water bottle on an area where menthol has been applied. This can cause excessive absorption and severe burns.
• Tight Bandaging: Do not wrap the treated area tightly with bandages, as this increases the risk of skin irritation and systemic toxicity.

No routine lab tests are required for standard topical use. However, if using menthol as part of a diagnostic allergen panel, healthcare providers will monitor the skin for 48 to 72 hours to evaluate the reaction.

Topical menthol does not typically interfere with the ability to drive or operate machinery. However, if oral ingestion occurs, dizziness may result, and these activities should be avoided.

There are no known direct interactions between topical menthol and alcohol. However, alcohol can cause vasodilation, which might theoretically increase the absorption of menthol if applied over large areas.

Menthol can be stopped abruptly without a tapering schedule. If pain persists for more than 7 days or clears up and occurs again within a few days, consult a doctor as this may indicate a more serious underlying condition.

> Important: Discuss all your medical conditions with your healthcare provider before starting Menthol, Unspecified Form.

There are no absolute drug-drug contraindications for topical menthol. However, it should not be used simultaneously with other topical medications on the same skin site unless directed by a physician, as this can alter the absorption of both drugs.

• Warfarin (Coumadin): There are rare case reports suggesting that topical menthol/methyl salicylate products may increase the blood-thinning effects of warfarin, leading to an increased risk of bruising or bleeding. Patients on anticoagulants should use menthol products with caution.
• Topical NSAIDs (e.g., Diclofenac gel): Using menthol alongside topical anti-inflammatories may increase skin permeability, potentially leading to higher systemic levels of the NSAID.

• Local Anesthetics: Use with other 'caine' anesthetics (like lidocaine) may have additive effects on nerve conduction inhibition.

There are no significant food interactions with topical menthol. For oral lozenges, avoid consuming very hot liquids immediately after use, as the cooling sensation may mask the temperature and lead to accidental burns in the mouth.

• Peppermint Oil Supplements: Taking oral peppermint oil while using extensive topical menthol may increase the total systemic load of menthol, potentially increasing the risk of side effects like heartburn or dizziness.

Menthol, Unspecified Form is not known to interfere with common blood or urine laboratory tests. It may, however, interfere with skin patch testing for other allergens if applied to the test site shortly before the diagnostic procedure.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Hypersensitivity: Menthol, Unspecified Form must NEVER be used in individuals with a known severe allergy to menthol or peppermint oil. The mechanism involves an IgE-mediated response that can lead to airway constriction.
• Broken or Damaged Skin: Do not apply to skin that is blistered, burned, or has open wounds, as this leads to rapid systemic absorption and toxicity.

• Asthma: In some sensitive individuals, the strong vapors from menthol can trigger bronchospasm or an asthma attack. Use with caution in poorly controlled asthmatics.
• Severe Hepatic Disease: While topical absorption is low, patients with end-stage liver disease should avoid large-scale application due to impaired metabolism of any absorbed menthol.

Patients who are sensitive to Carvone (found in spearmint) or other terpene compounds may exhibit cross-sensitivity to Menthol, Unspecified Form. If you have a history of 'mint allergy,' a small patch test is recommended before full application.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Menthol, Unspecified Form.

Menthol, Unspecified Form is generally considered safe for localized topical use during pregnancy when used as directed. It is often categorized as FDA Pregnancy Category B (or equivalent). However, extensive use over large surface areas should be avoided, as there are no well-controlled studies on the effects of high systemic menthol levels on fetal development. Always consult a healthcare provider before use during the third trimester.

Menthol is excreted into breast milk in small amounts when ingested, but topical application to areas away from the breast is unlikely to affect a nursing infant. Crucial: Do not apply menthol-containing products to the breast or nipple area, as the infant may ingest the medication during nursing, which can lead to serious respiratory distress or choking.

Menthol is approved for use in children over 2 years of age in low concentrations (e.g., chest rubs). However, products with high concentrations (above 5-10%) are generally restricted to children over 12. Pediatric use requires strict supervision to prevent accidental contact with eyes or mouth.

Elderly patients are at a higher risk for skin breakdown. Clinical data suggests that the cooling sensation of menthol can sometimes mask the symptoms of underlying vascular issues in the limbs. Use with caution in patients with peripheral neuropathy or poor circulation.

No specific GFR-based dose adjustments are required for standard topical applications. Menthol is not effectively cleared by dialysis, but this is rarely a clinical concern given the route of administration.

In patients with Child-Pugh Class C impairment, systemic clearance of absorbed menthol is reduced. Limit use to small, localized areas and monitor for signs of systemic toxicity such as lethargy or confusion.

> Important: Special populations require individualized medical assessment.

Menthol, Unspecified Form is a TRPM8 agonist. TRPM8 is an ion channel that, when activated by menthol or cold temperatures, allows the entry of sodium and calcium ions into the cell, resulting in depolarization of the sensory neuron and the perception of a 'cooling' sensation. It also exhibits desensitization of nociceptors (pain receptors) over time and inhibits voltage-gated sodium channels similarly to amide local anesthetics.

Onset of the cooling sensation typically occurs within 1-5 minutes of topical application. The duration of the analgesic effect usually lasts between 30 minutes and 2 hours. Menthol does not appear to cause significant pharmacological tolerance with intermittent use.

| Parameter | Value |

|---|---|

| Bioavailability | <5% (Topical); High (Oral) |

| Protein Binding | ~25% |

| Half-life | 3-6 hours |

| Tmax | 0.5 - 1 hour (Oral/Buccal) |

| Metabolism | Hepatic (Glucuronidation) |

| Excretion | Renal (>90% as metabolites) |

• Molecular Formula: C10H20O
• Molecular Weight: 156.27 g/mol
• Solubility: Slightly soluble in water; highly soluble in alcohol, ether, and chloroform.
• Structure: A cyclohexane ring with a hydroxyl group, a methyl group, and an isopropyl group.

Menthol is classified as a cyclic terpene alcohol and is therapeutically grouped with counterirritants and topical analgesics.